IL-2-Induced IL-5 Synthesis, but Not Proliferation, of Human CD4+ T Cells Is Suppressed by FK506

Journal of Immunology

Volumn 158, Issue 8, 1997, Pages 3659-3665

  Mori, Akio ^a   Suko, Matsunobu ^a   Kaminuma, Osamu ^a   Inoue, Satoshi ^a   Ohmura, Takeo ^a   Hoshino, Akihiko ^a   Asakura, Yumiko ^a   Terada, Eiji ^b   Miyazawa, Keiji ^a   Nosaka, Chihiro ^c   Okumura, Yasushi ^d   Ito, Koji ^a   Okudaira, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

^d ASAHI BREWERIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 5; TACROLIMUS;

ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CLONE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; HUMAN; IMMUNOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CLONE CELLS; DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-5; TACROLIMUS;

EID: 0031569575     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Frigas, E., and G. J. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 77:527.
2. +) T cells and eosinophils in allergy and asthma. Am. Rev. Respir. Dis. 145:S22.
3. Gleich, G. J., and C. R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39:177.
4. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
5. Corrigan, C. T., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501.
6. Robinson, D. S. 1993. Interleukin-5, eosinophils and bronchial hyperreactivity. Clin. Exp. Allergy 23:1.
7. Sanderson, C. J., H. D. Campbell, and I. G. Young. 1988. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol. Rev. 102:29.
8. Takatsu, K., S. Takaki, and Y. Hitoshi. 1994. Interleukin-5 and its receptor system: implication in the immune system and inflammation. Adv. Immunol. 57:145.
9. Ohnishi, T., H. Kita, D. Weiler, S. Sur, J. B. Sedgwick, W. J. Calhoun, W. W. Busse, J. S. Abrams, and G. J. Gleich. 1993. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:901.
10. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, J. Quint, and A. B. Kay. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541.
11. + T cells, increased Th2 type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313.
12. Gulbenkian, A. R., R. W. Egan, X. Fernandez, H. Jones, W. Kreutner, T. Kung, F. Payvandi, L. Sullivan, J. A. Zurcher, and A. S. Watnick. 1992. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am. Rev. Respir. Dis. 146:263.
13. Chand, N., J. E. Harrison, S. Rooney, J. Pillar, R. Jakubicki, K. Nolan, W. Diamantis, and R. D. Sofia. 1992. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur. J. Pharmacol. 211:121.
14. Mauser, P. J., A. Pitman. A. Wilt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A. S. Watnick, R. W. Egan, W. Kreutner, and G. K. Adams. 1993. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623.
15. Van Oosterhout, A. J. M., A. R. C. Ladenius, H. F. J. Savelkoul, I. V. Ark, K. C. Delsman, and F. P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548.
16. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immunol. 7:449.
17. Schreiber, S. L. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283.
18. Nakagawa, H., T. Etoh, Y. Ishibashi, Y. Higaki, M. Kawashima, H. Torii, and S. Harada. 1994. Tacrolimus ointment for atopic dermatitis. Lancet 344:883.
19. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136.
20. Riegel, J. S., B. Corthesy, W. M. Flanagan, and G. R. Crabtree. 1992. Regulation of the interleukin-2 gene. In Chemical Immunology, Vol. 51. T. Kishimoto, ed. Karger, Basel, p. 266.
21. Liu, L. 1993. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol. Today 14:290.
22. Tooci, M. J., D. A. Matkovich, K. A. Collier, P. Kwok, F. Dumont, S. Lin, S. Degudicibus, J. J. Siekierka, J. Chin, and N. I. Hutchinson. 1989. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143:718.
23. Wang, S. C, A. Zeevi, M. L. Jordan, R. L. Simmons, and D. J. Tweardy. 1991. FK506, repamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc. 23:2920.
24. Wang, S. C., P. A. Morel, Q. Wang, M. L. Jordan, R. L. Simmons, and D. J. Tweardy. 1993. A dual mechanism of immunosuppression by FK506: differential suppression of IL-4 and IL-10 levels in T helper 2 cells. Transplantation 56:978.
25. Okamoto, S., N. Mukaida, K. Yasumoto, N. Rice, Y. Ishikawa, H. Horiguchi, S. Murakami, and K. Matsushima. 1994. The interleukin-8 AP-1 and kB-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J. Biol. Chem. 269:8582.
26. Bohjanen, P. R., M. Okajima, and R. J. Hodes. 1990. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell· gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc. Natl. Acad. Sci. USA 87:5283.
27. Naora, H., J. G. Altin, and I. G. Young. 1994. TCR-dependent and -independent signaling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone D10.G4.1. J. Immunol. 152:5691.
28. Mori, A., M. Suko, N. Tsuruoka, O. Kaminuma, T. Ohmura, Y. Nishizaki, K. Ito, and H. Okudaira. 1995. Allergen-specific human T cell clones produce IL-5 upon stimulation with Th1 cytokine, IL-2. Int. Arch. Allergy Immunol. 107:220.
29. Waldmann, T. A. 1991. The interleukin-2 receptor. J. Biol. Chem. 266:2681.
30. Gaulton, G. N., and P. Williamson. 1994. Interleukin-2 and the interleukin-2 receptor complex. In Chemical Immunology, Vol. 59. L. E. Samelson, ed. Karger, Basel, p. 91.
31. Weiss, A., J. Imboden, D. Shoback, and S. Stobo. 1984. Role of T3 surface molecules in human T-cell activation: T-cell-dependent activation results in an increase in cytoplasmic free calcium. Prac. Natl. Acad. Sci. USA 81:4169.
32. Mills, G. B., R. K. Cheung, S. Grinstein, and E. W. Gelfand. 1985. Interleukin 2-induced lymphocyte proliferation is independent of increases in cytosolic-free calcium concentrations. J. Immunol. 134:2431.
33. Valge, V. E., J. G. P. Wong, B. M. Datlof, A. J. Sinskey, and A. Rao. 1998. Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell 55:101.
34. Redondo, J. M., A. Lopez-Rivas, V. Vila, E. J. Cragoe, Jr., and M. Fresno. 1988. The role of protein kinase C in lymphocyte proliferation: existence of protein kinase C-dependent and -independent pathways. J. Biol. Chem. 263:17467.
35. Mills, G. B., D. J. Stewart, A. Mellors, and E. W. Gelfand. 1986. Interleukin 2 does not induce phosphatidylinositol hydrolysis in activated T cells. J. Immunol. 136:3019.
36. Rosen, M. K., and S. L. Schreiber. 1992. Natural products as probes of cellular function: studies of immunophilins. Angew. Chem. Int. Ed. Engl. 31:384.
37. Morris, R. E. 1991. Rapamycin: FK506's fraternal twin or distant cousin? Immunol. Today 12:137.
38. Dumont, F. J., M. J. Staruch, S. L. Koprak, M. R. Melino, and N. H. Sigal. 1990. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144:251.
39. Bierer, B. E., P. S. Mattila, R. F. Standaert, L. A. Herzenberg, S. J. Burakoff, G. Crabtree, and S. L. Schreiber. 1990. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl. Acad. Sci. USA 87:9231.
40. Yuuki, T., Y. Okumura, T. Ando, H. Yamakawa, M. Suko, M. Haida, and H. Okudaira. 1991. Cloning and expression of cDNA for the major house dust mite allergen Der f II in Escherichia colt. Agric. Biol. Chem. 55:1233.
41. Mori, A., M. Suko, O. Kaminuma, S. Inoue, T. Ohmura, Y. Nishizaki, T. Nagahori, Y. Asakura, A. Hoshino, Y. Okumura, G. Sato, K. Ito, and H. Okudaira. 1996. IL-15 promotes cytokine production of human helper T cells. J. Immunol. 156:2391.
42. Fukuda, Y., J. Hashino, M. Haruyama, N. Tsuruoka, H. Nakazato, and T. Nakanishi. 1991. A sandwich enzyme-linked immunosorbent assay for human interleukin-5. J. Immunol. Methods 143:89.
43. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
44. Tanabe, T., M. Konishi, T. Mizuta, T. Noma, and T. Honjo. 1987. Molecular cloning and structure of the human interleukin-5 gene. J. Biol. Chem. 262:16580.
45. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:6419.
46. Lin, C. S., R. C. Boltz, J. J. Siekierka, and N. H. Sigal. 1991, FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. Cell. Immunol. 133:269.
47. Honami, N., and I. G. Young. 1994. Mechanisms regulating the mRNA levels of interleukin-5 and two other coordinately expressed lymphokines in the murine T lymphoma EL4.23. Blood 83:3620.
48. Bourke, P. F., B. H. van Leeuwen, H. D. Campbell, and I. G. Young. 1995. Localization of the inducible enhancer in the mouse interleukin-5 gene that is responsive to T-cell receptor stimulation. Blood 85:2069.
49. Stranick, K. S., F. Payvandi, D. N. Zambas, S. P. Umland, R. W. Egan, and M. M. Billah. 1995. Transcription of the murine interleukin 5 gene is regulated by multiple promoter elements. J. Biol. Chem. 270:20575.
50. Fruman, D. A., S.-Y. Pay, S. J. Burakoff, and B. E. Bierer. 1995. Characterization of a mutant calcineurin Aα gene expressed by EL4 lymphoma cells. Mol. Cell. Biol. 15:3857.
51. Gajewski, T. F., and F. W. Fitch. 1991. Differential activation of murine Th1 and Th2 clones. J. Immunol. 142:19.
52. + T cell subsets. J. Immunol. 152:77.
53. Emmel, E. A., C. L. Verweij, D. B. Durand, K. M. Higgins, E. Lacy, and G. R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246:1617.
54. Mattila, P. S., K. S. Ullman, S. Fiering, E. A. Emmel, M. McCutcheon, G. R. Crabtree, and L. A. Herzenberg. 1990. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9:4425.
55. Tigges, M. A., L. S. Casey, and M. E. Koshland. 1989. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 243:781.
56. Merida, I., E. Diez, and G. N. Gaulton. 1991. IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. J. Immunol. 147:2202.
57. lck: identification of novel intermolecular association. Science 252:1523.
58. Kozumbo, W. J., D. T. Harris, S. Gromkowski, J.-C. Cerottini, and P. A. Cerutti. 1987. Molecular mechanisms involved in T cell activation. II. The phosphatidylinositol signal-transducing mechanism mediates antigen-induced lymphokine production but not interleukin 2-induced proliferation in cloned cytotoxic T lymphocytes. J. Immunol. 138:606.
59. Altman, A., K. M. Coggeshall, and T. Mustelin. 1990. Molecular events mediating T cell activation. Adv. Immunol. 48:227.
60. Altman, A., T. Mustelin, and K. M. Coggeshall. 1990. T lymphocyte activation: a biological model of signal transduction. CRC Crit. Rev. Immunol. 10:347.